Skip to main content

MRA Recalls Four Medical Marijuana Products Across the State

Media Contact: LARA Communications 517-335-LARA (5272)

August 30, 2019 – The Marijuana Regulatory Agency (MRA) issued a health and safety bulletin today recalling four medical marijuana products as a result of the ongoing investigation into the testing and reporting practices of Iron Laboratories.

The recalled marijuana products were sold by licensed medical marijuana Provisioning Centers in the following cities:

  • Battle Creek
  • Bay City
  • Burton
  • Chesaning
  • Detroit
  • Ferndale
  • Flint
  • Inkster
  • Jackson
  • Kalamazoo
  • River Rouge
  • Rogers City
  • Vassar
  • Wayne
  • Ypsilanti   

The following marijuana products have been recalled:

  • RSO 1G. SYRINGE-MONSTER X-, failed testing on 5/2/19 for Chemical Residue – Bifenazate
  • Glue-Buds, failed testing on 6/14/19 for Heavy Metal - Cadmium
  • 1g Savage Signature OG Budder, concentrate, failed testing on 7/17/19 for Heavy Metal- Arsenic 
  • 1g - Platinum Vapes - Diamond OG Cartridge, failed testing on 6/25/19 for Heavy Metal - Total Chromium

Possible medical issues or symptoms could include coughing, wheezing, decreased pulmonary function, nausea, vomiting, abnormal heart rhythm, and damage to blood vessels.

All affected medical marijuana is required to have a label affixed to the container that indicates the METRC number assigned to the marijuana product. Patients and caregivers should look for any of the METRC numbers mentioned in the recall.

Patients or caregivers who have these affected medical marijuana products in their possession should destroy them or return them to the provisioning center from which they were purchased.

"We take the testing of medical marijuana product very seriously,” said MRA Executive Director Andrew Brisbo. “Our first focus is on making sure that the marijuana product in the regulated industry meets established safety standards.”

The MRA summarily suspended the license of Iron Laboratories – and issued a related health and safety bulletin – on August 16, 2019.

The MRA has not been made aware of any adverse product reactions in conjunction with product tested by Iron Laboratories; however, the MRA is continuing to investigate this matter and will issue further bulletins if appropriate. Patients and caregivers are requested to report any adverse product reactions to the MRA via email: or via phone: 517-284-8597.

Patients and caregivers who would like to have products tested – at their own expense – can take them to a licensed safety compliance facility. Questions can be sent to Operations Support Section via email at

Connect with us image

Facebook logoTwitter BirdYouTube IconLARA IconBMR icon